![]() Celentyx Celentyx is a human immune system focused company specializing in immuno-oncology, inflammation, and autoimmunity in vitro assays. | ![]() Genomicare Biotechnology GenomiCare is a biotech and pharmaceutical company that is an expert in oncology solutions for cancer patients. | Invenra Invenra is a company focused on developing biologics with an emphasis on multispecific antibodies and their derivatives. | Ascentage Pharma Ascentage Pharma Group International (亚盛闘棄集團) is a biopharmaceutical company that is engaged in discovering, developing, and commercializing therapies. | ![]() Loxo Oncology Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations. | |
Founding Date | Founding Date 2007 | Founding Date 2015 | Founding Date 2011 | Founding Date 2017 | Founding Date 2013 |
Type | Type Private | Type Private | Type Private | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Birmingham, GB HQ Oxford, GB | Locations Haverford, US HQ | Locations Madison, US HQ | Locations Suzhou, CN HQ Guangzhou Shi, CN Suzhou Shi, CN Taizhou, CN Rockville, US | Locations Stamford, US HQ Alcobendas, ES Boulder, US New York, US South San Francisco, US |
Employees | Employees 12 | Employees 21 | Employees 582% increase | Employees 567 | Employees 65610% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥574.1m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income (¥1.2b) (FY, 2025) | Net income ($148.9m) (FY, 2017) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 22m | Total funding raised $ 237.5m | Total funding raised $ 57m |

GenomiCare is a biotech and pharmaceutical company that is an expert in oncology solutions for cancer patients.
View companyInvenra is a company focused on developing biologics with an emphasis on multispecific antibodies and their derivatives.
View companyAscentage Pharma Group International (亚盛闘棄集團) is a biopharmaceutical company that is engaged in discovering, developing, and commercializing therapies.
View company
Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.
View company